A novel approach for tailored medicines: Direct writing of Janus fibers

Zhi Cheng Yao, Jun Chuan Wang, Baolin Wang, Zeeshan Ahmad, Jing Song Li, Ming Wei Chang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recent explorations have shown potential drug delivery applications of random and aligned fibrous dosage forms (e.g. patches, dressings, films and inserts). In this study, novel controlled delivery dosage forms, comprising Janus fibers, are designed and fabricated using electrohydrodynamic (EHD) engineering. Model probe and active compound release is shown from dissimilar polymer systems (non-soluble and soluble in nature) which constitute towards Janus systems. Micron scaled aligned Janus fibers comprising polycaprolactone (PCL) and polyvinyl pyrrolidone (PVP) were engineered to host rhodamine B and acriflavine, respectively. The impact of various operating parameters (e.g. flow rate, collector speed, working distance and applied voltage) on resulting mean fiber diameter and shape were optimized. Tensile strain decreased from 116.5 ± 10.2% to 81.8 ± 9.5% upon the inclusion of the model compounds, while both PCL/PVP and PCL/PVP/dyes samples exhibited similar tensile strength (∼0.65 MPa). FTIR analyses demonstrates PCL/PVP blend behavior and successful incorporation of rhodamine B and acriflavine. Acriflavine release from PCL fibers spanned over a 4-day period, and release of rhodamine B from PVP fibers was just over 6 h. The results indicate the EHD direct-jetting technique enables the precise construction of drug loaded and aligned fibers in a single-step with minimal excipient usage for potential customized drug delivery.

LanguageEnglish
Pages372-379
Number of pages8
JournalJournal of Drug Delivery Science and Technology
Volume50
Early online date8 Feb 2019
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

rhodamine B
Polyvinyls
Pyrrolidinones
Acriflavine
Dosage Forms
Designer Drugs
Tensile Strength
Excipients
Fourier Transform Infrared Spectroscopy
Bandages
Pharmaceutical Preparations
Polymers
Coloring Agents
polycaprolactone

Keywords

  • Alignment
  • Dual release
  • Electrohydrodynamic direct-jetting
  • Janus fiber
  • Patterning

Cite this

Yao, Zhi Cheng ; Wang, Jun Chuan ; Wang, Baolin ; Ahmad, Zeeshan ; Li, Jing Song ; Chang, Ming Wei. / A novel approach for tailored medicines: Direct writing of Janus fibers. 2019 ; Vol. 50. pp. 372-379.
@article{c9ad9964451445fea5f20a5797f6b24b,
title = "A novel approach for tailored medicines: Direct writing of Janus fibers",
abstract = "Recent explorations have shown potential drug delivery applications of random and aligned fibrous dosage forms (e.g. patches, dressings, films and inserts). In this study, novel controlled delivery dosage forms, comprising Janus fibers, are designed and fabricated using electrohydrodynamic (EHD) engineering. Model probe and active compound release is shown from dissimilar polymer systems (non-soluble and soluble in nature) which constitute towards Janus systems. Micron scaled aligned Janus fibers comprising polycaprolactone (PCL) and polyvinyl pyrrolidone (PVP) were engineered to host rhodamine B and acriflavine, respectively. The impact of various operating parameters (e.g. flow rate, collector speed, working distance and applied voltage) on resulting mean fiber diameter and shape were optimized. Tensile strain decreased from 116.5 ± 10.2{\%} to 81.8 ± 9.5{\%} upon the inclusion of the model compounds, while both PCL/PVP and PCL/PVP/dyes samples exhibited similar tensile strength (∼0.65 MPa). FTIR analyses demonstrates PCL/PVP blend behavior and successful incorporation of rhodamine B and acriflavine. Acriflavine release from PCL fibers spanned over a 4-day period, and release of rhodamine B from PVP fibers was just over 6 h. The results indicate the EHD direct-jetting technique enables the precise construction of drug loaded and aligned fibers in a single-step with minimal excipient usage for potential customized drug delivery.",
keywords = "Alignment, Dual release, Electrohydrodynamic direct-jetting, Janus fiber, Patterning",
author = "Yao, {Zhi Cheng} and Wang, {Jun Chuan} and Baolin Wang and Zeeshan Ahmad and Li, {Jing Song} and Chang, {Ming Wei}",
note = "Ming-Wei was not employed in the UK at the time of acceptance or publication. No accepted version, not for REF.",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jddst.2019.02.006",
language = "English",
volume = "50",
pages = "372--379",

}

A novel approach for tailored medicines: Direct writing of Janus fibers. / Yao, Zhi Cheng; Wang, Jun Chuan; Wang, Baolin; Ahmad, Zeeshan; Li, Jing Song; Chang, Ming Wei.

Vol. 50, 01.04.2019, p. 372-379.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel approach for tailored medicines: Direct writing of Janus fibers

AU - Yao, Zhi Cheng

AU - Wang, Jun Chuan

AU - Wang, Baolin

AU - Ahmad, Zeeshan

AU - Li, Jing Song

AU - Chang, Ming Wei

N1 - Ming-Wei was not employed in the UK at the time of acceptance or publication. No accepted version, not for REF.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Recent explorations have shown potential drug delivery applications of random and aligned fibrous dosage forms (e.g. patches, dressings, films and inserts). In this study, novel controlled delivery dosage forms, comprising Janus fibers, are designed and fabricated using electrohydrodynamic (EHD) engineering. Model probe and active compound release is shown from dissimilar polymer systems (non-soluble and soluble in nature) which constitute towards Janus systems. Micron scaled aligned Janus fibers comprising polycaprolactone (PCL) and polyvinyl pyrrolidone (PVP) were engineered to host rhodamine B and acriflavine, respectively. The impact of various operating parameters (e.g. flow rate, collector speed, working distance and applied voltage) on resulting mean fiber diameter and shape were optimized. Tensile strain decreased from 116.5 ± 10.2% to 81.8 ± 9.5% upon the inclusion of the model compounds, while both PCL/PVP and PCL/PVP/dyes samples exhibited similar tensile strength (∼0.65 MPa). FTIR analyses demonstrates PCL/PVP blend behavior and successful incorporation of rhodamine B and acriflavine. Acriflavine release from PCL fibers spanned over a 4-day period, and release of rhodamine B from PVP fibers was just over 6 h. The results indicate the EHD direct-jetting technique enables the precise construction of drug loaded and aligned fibers in a single-step with minimal excipient usage for potential customized drug delivery.

AB - Recent explorations have shown potential drug delivery applications of random and aligned fibrous dosage forms (e.g. patches, dressings, films and inserts). In this study, novel controlled delivery dosage forms, comprising Janus fibers, are designed and fabricated using electrohydrodynamic (EHD) engineering. Model probe and active compound release is shown from dissimilar polymer systems (non-soluble and soluble in nature) which constitute towards Janus systems. Micron scaled aligned Janus fibers comprising polycaprolactone (PCL) and polyvinyl pyrrolidone (PVP) were engineered to host rhodamine B and acriflavine, respectively. The impact of various operating parameters (e.g. flow rate, collector speed, working distance and applied voltage) on resulting mean fiber diameter and shape were optimized. Tensile strain decreased from 116.5 ± 10.2% to 81.8 ± 9.5% upon the inclusion of the model compounds, while both PCL/PVP and PCL/PVP/dyes samples exhibited similar tensile strength (∼0.65 MPa). FTIR analyses demonstrates PCL/PVP blend behavior and successful incorporation of rhodamine B and acriflavine. Acriflavine release from PCL fibers spanned over a 4-day period, and release of rhodamine B from PVP fibers was just over 6 h. The results indicate the EHD direct-jetting technique enables the precise construction of drug loaded and aligned fibers in a single-step with minimal excipient usage for potential customized drug delivery.

KW - Alignment

KW - Dual release

KW - Electrohydrodynamic direct-jetting

KW - Janus fiber

KW - Patterning

UR - http://www.scopus.com/inward/record.url?scp=85061524711&partnerID=8YFLogxK

U2 - 10.1016/j.jddst.2019.02.006

DO - 10.1016/j.jddst.2019.02.006

M3 - Article

VL - 50

SP - 372

EP - 379

ER -